scholarly article | Q13442814 |
P50 | author | Paolo Bonanni | Q47135409 |
Donatella Panatto | Q53193866 | ||
Daniela Amicizia | Q59767479 | ||
Piero Luigi Lai | Q61658992 | ||
P2093 | author name string | Alessandro Rinaldi | |
Angela Bechini | |||
Anna Maria Ferriero | |||
Francesco Saverio Mennini | |||
Sara Boccalini | |||
Andrea Marcellusi | |||
Federico Manzi | |||
Chiara Bini | |||
Gino Sartor | |||
Maddalena Innocenti | |||
Emanuela Rizzitelli | |||
Francesca Trippi | |||
Francesca Zangrillo | |||
Giovanni Checcucci Lisi | |||
Mariasilvia Iovine | |||
P2860 | cites work | A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children | Q95816388 |
Impact of influenza infection in healthy children examined as outpatients and their families | Q83945158 | ||
Vaccines against influenza WHO position paper – November 2012 | Q85607288 | ||
[The concept of Health Literacy and its importance for nursing] | Q87046796 | ||
Epidemiology and etiology of childhood pneumonia | Q22241278 | ||
Vaccines for preventing influenza in healthy children | Q24201525 | ||
Vaccines for preventing influenza in healthy children | Q24243174 | ||
The evolution of human influenza viruses | Q24522380 | ||
Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses | Q24614487 | ||
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem? | Q26748155 | ||
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis | Q26751854 | ||
The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper | Q26773027 | ||
Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients | Q27302304 | ||
Vaccine coverage in Italy and assessment of the 2012-2014 National Immunization Prevention Plan | Q28269077 | ||
The use of social networking sites for public health practice and research: a systematic review | Q28660520 | ||
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | Q28742719 | ||
Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren | Q28743079 | ||
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis | Q28748161 | ||
Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
Influenza-associated hospitalizations in the United States | Q29619463 | ||
Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008. | Q30227419 | ||
Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. | Q30353232 | ||
Inactivated and adjuvanted influenza vaccines. | Q30364870 | ||
Social contact networks for the spread of pandemic influenza in children and teenagers | Q30367764 | ||
Ten years (2004-2014) of influenza surveillance in Northern Italy | Q30369473 | ||
Incubation periods of acute respiratory viral infections: a systematic review. | Q30376497 | ||
Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. | Q30379228 | ||
Complications of seasonal and pandemic influenza. | Q30382814 | ||
Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics? | Q30403017 | ||
Influenza myocarditis and myositis: case presentation and review of the literature | Q30403565 | ||
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. | Q30407148 | ||
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. | Q30408354 | ||
Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis | Q30408657 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Identifying strategies to increase influenza vaccination in GP practices: a positive deviance approach. | Q39879668 | ||
Influenza: its antigenic variation and ecology | Q40031533 | ||
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season | Q40070473 | ||
Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community | Q40075443 | ||
The future of best investing in vaccines: the Health Technology Assessment approach | Q40121721 | ||
Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy. | Q40122593 | ||
Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials | Q40143562 | ||
Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. | Q40311136 | ||
Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15. | Q40355918 | ||
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results | Q40357312 | ||
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study | Q40373417 | ||
Influenza A and febrile seizures in childhood. | Q40463397 | ||
The underrecognized burden of influenza in young children. | Q40475111 | ||
Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. | Q40521075 | ||
Influenza A and B virus infections in children | Q40567104 | ||
Influenza A infection is an important cause of febrile seizures | Q40595648 | ||
Influenza vaccine in healthy preschool children | Q40603983 | ||
Prevention and Control of Seasonal Influenza with Vaccines | Q40607746 | ||
Assessment of effectiveness of Vaxigrip | Q40633500 | ||
Febrile Seizure Risk After Vaccination in Children 6 to 23 Months | Q40713270 | ||
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results | Q40802753 | ||
Febrile Seizure Risk after Vaccination in Children One to Five Months of Age. | Q41928717 | ||
Influenza vaccine use to protect healthy children: A debated topic | Q41934389 | ||
The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015. | Q41987697 | ||
Acute otitis media and respiratory virus infections | Q42153237 | ||
Immunogenicity and safety of inactivated quadrivalent and trivalent influenza vaccines in children 18-47 months of age. | Q42181750 | ||
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial | Q42239677 | ||
Influenza-associated pediatric deaths in the United States, 2004-2012. | Q42259236 | ||
Emergency Department demand associated with seasonal influenza, 2010 through 2014, New South Wales, Australia. | Q42374407 | ||
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home | Q42905616 | ||
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai | Q43173658 | ||
Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan | Q43177217 | ||
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children | Q43177458 | ||
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. | Q43207722 | ||
The Japanese experience with vaccinating schoolchildren against influenza | Q43209480 | ||
TYPE B INFLUENZA IN SINGAPORE. | Q43210721 | ||
A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season | Q43210853 | ||
An epidemic of influenza B in Australia | Q43681796 | ||
Vaccine effectiveness against laboratory-confirmed influenza in infants: A matched case control study | Q44110746 | ||
Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system | Q44194786 | ||
High costs of influenza: Direct medical costs of influenza disease in young children | Q44816877 | ||
Role of non-traditional locations for seasonal flu vaccination: Empirical evidence and evaluation | Q45057572 | ||
Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. | Q45218285 | ||
Molecular epidemiology of influenza B virus among hospitalized pediatric patients in Northern Italy during the 2015-16 season. | Q45326028 | ||
Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? | Q45397635 | ||
Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010-2017). | Q46268239 | ||
Clinical manifestations and socio-economic impact of influenza among healthy children in the community | Q46606837 | ||
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study | Q46876629 | ||
Characteristics and outcomes of influenza-associated encephalopathy cases among children and adults in Japan, 2010-2015. | Q47182048 | ||
Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17. | Q47185746 | ||
Estimating the Population Impact of a New Pediatric Influenza Vaccination Program in England Using Social Media Content. | Q47187065 | ||
Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers | Q47195857 | ||
Preventing influenza in younger children | Q30420046 | ||
Neurologic complications of influenza | Q30420315 | ||
Renal complications of seasonal and pandemic influenza A virus infections | Q30422342 | ||
The burden of seasonal and pandemic influenza in infants and children | Q30430303 | ||
Impact of seasonal and pandemic influenza on emergency department visits, 2003-2010, Ontario, Canada | Q30430972 | ||
Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family | Q30770154 | ||
Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review | Q30847472 | ||
Public health literacy defined | Q33429448 | ||
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study | Q33434855 | ||
Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season. | Q33553117 | ||
In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen | Q33820732 | ||
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. | Q34047266 | ||
Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system | Q34099150 | ||
Influenza hemagglutinin and neuraminidase membrane glycoproteins | Q34121109 | ||
School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance | Q34137789 | ||
Risk factors of influenza transmission in households | Q34249434 | ||
Burden of paediatric influenza in Western Europe: a systematic review | Q34475023 | ||
Clinical characteristics of acute viral lower respiratory tract infections in hospitalized children in Seoul, 1996-1998. | Q34655701 | ||
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults | Q34729188 | ||
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis | Q34783486 | ||
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years | Q34862926 | ||
The clinical and etiological characteristics of influenza-like illness (ILI) in outpatients in Shanghai, China, 2011 to 2013 | Q35231245 | ||
Mortality in children from influenza and respiratory syncytial virus | Q35559491 | ||
Promotion of influenza vaccination among health care workers: findings from a tertiary care children's hospital in Italy. | Q35708648 | ||
Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study | Q35740809 | ||
An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies | Q35744237 | ||
Influenza vaccination among healthcare workers in Italy | Q35886973 | ||
Low vaccination coverage among italian healthcare workers in 2013. | Q35887577 | ||
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. | Q35906893 | ||
Could university training and a proactive attitude of coworkers be associated with influenza vaccination compliance? A multicentre survey among Italian medical residents. | Q35910128 | ||
Safety of the trivalent inactivated influenza vaccine among children: a population-based study | Q35936147 | ||
Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice | Q35981831 | ||
Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries. | Q36129250 | ||
Incidence of influenza and associated illness in children aged 0-19 years: a systematic review | Q36264226 | ||
Immunization attitudes and beliefs among parents: beyond a dichotomous perspective. | Q47302554 | ||
Viral etiologies and epidemiology of patients with acute respiratory infections based on sentinel hospitals in Gansu Province, Northwest China, 2011-2015. | Q47547249 | ||
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection | Q47549279 | ||
Vaccines for preventing influenza in healthy children | Q47638511 | ||
Burden of influenza in children in the community | Q47924586 | ||
Human metapneumovirus and lower respiratory tract disease in children | Q47990064 | ||
Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. | Q48012524 | ||
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy. | Q48145472 | ||
Health literacy and vaccination: A systematic review | Q48161399 | ||
Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial | Q49057993 | ||
Health literacy, emotionality, scientific evidence: Elements of an effective communication in public health. | Q49580188 | ||
Influenza-Associated Pediatric Deaths in the United States, 2010-2016. | Q50026189 | ||
Parental vaccine hesitancy in Italy - Results from a national survey. | Q50079937 | ||
Updates on Influenza Vaccination in Children | Q50180208 | ||
Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults | Q50420352 | ||
Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. | Q50690322 | ||
Risk Communication, Values Clarification, and Vaccination Decisions. | Q50915746 | ||
Population-wide benefits of routine vaccination of children against influenza. | Q51980197 | ||
Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. | Q52547725 | ||
The Influence of Provider Communication Behaviors on Parental Vaccine Acceptance and Visit Experience. | Q54463592 | ||
Confidence in vaccination: a parent model. | Q54522494 | ||
Influenza Vaccination Strategies Should Target Children | Q56794483 | ||
A revision of the system of nomenclature for influenza viruses: a WHO memorandum | Q56941030 | ||
Influenza | Q57120491 | ||
Influenza-Associated Deaths among Children in the United States, 2003–2004 | Q57385012 | ||
Influenza vaccine in healthy children: a meta-analysis | Q57560041 | ||
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons | Q57927674 | ||
The burden of influenza B: a structured literature review | Q57943670 | ||
The ethics of influenza vaccination | Q58659412 | ||
Quadrivalent inactivated influenza vaccine (VaxigripTetra™) | Q59351929 | ||
Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media | Q59506045 | ||
Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children | Q61848833 | ||
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981 | Q69262720 | ||
Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease | Q72205122 | ||
The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy | Q77337552 | ||
Prophylactic effect of inactivated influenza vaccine on young children | Q78024894 | ||
Effectiveness of school-based influenza vaccination | Q79431476 | ||
The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality | Q79679969 | ||
Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season | Q81235322 | ||
Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses | Q81920819 | ||
Parental perception of influenza in Italy: a web survey | Q82408666 | ||
Commentary: benefits of influenza vaccine in US elderly--new studies raise questions | Q36348297 | ||
Estimating influenza hospitalizations among children | Q36403778 | ||
Detection of influenza C virus but not influenza D virus in Scottish respiratory samples | Q36456135 | ||
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus | Q36470030 | ||
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. | Q36633877 | ||
A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years | Q36846234 | ||
Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons | Q36964157 | ||
Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States | Q36977877 | ||
Facebook Advertising Across an Engagement Spectrum: A Case Example for Public Health Communication. | Q37000260 | ||
Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis | Q37011575 | ||
Influenza-associated central nervous system dysfunction: a literature review | Q37166293 | ||
An observational study of febrile seizures: the importance of viral infection and immunization. | Q37470267 | ||
Attitudinal variables and a possible mediating mechanism for vaccination practice in health care workers of a local hospital in L'Aquila (Italy) | Q37619146 | ||
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy. | Q37669436 | ||
The need for quadrivalent vaccine against seasonal influenza | Q37780348 | ||
Influenza-related viral myocarditis | Q37800086 | ||
Effectiveness and safety of influenza vaccination in children: European perspective | Q37912505 | ||
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | Q37955413 | ||
The rationale for quadrivalent influenza vaccines | Q37976542 | ||
Effects of influenza on pregnant women and infants | Q38037607 | ||
Acute sinusitis in children | Q38088457 | ||
The evolving history of influenza viruses and influenza vaccines | Q38136296 | ||
A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in Japan | Q38241368 | ||
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial | Q38375196 | ||
Management of two influenza vaccination campaign in health care workers of a university hospital in the south Italy | Q38401703 | ||
Fluarix quadrivalent vaccine for influenza | Q38534169 | ||
Influenza as a trigger for cardiovascular disease: An investigation of serotype, subtype and geographic location | Q38800824 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance | Q38845565 | ||
Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. | Q38928500 | ||
Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review | Q39188630 | ||
Influenza vaccination of schoolchildren and influenza outbreaks in a school | Q39204971 | ||
Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample | Q39352336 | ||
Parental knowledge, attitudes and behaviours towards influenza A/H1N1 in Italy. | Q39713558 | ||
P433 | issue | 1 Suppl 1 | |
P921 | main subject | Italy | Q38 |
P304 | page(s) | E1-E86 | |
P577 | publication date | 2018-05-30 | |
P1433 | published in | Journal of preventive medicine and hygiene | Q26842091 |
P1476 | title | [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] | |
P478 | volume | 59 |
Search more.